NASDAQ
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
Open
$10.30
Previous Close
$10.24
Day High
$10.72
Day Low
$10.02
52 Week High
$18.90
52 Week Low
$6.66
No price data available for this timeframe.